tirzepatide compared to semaglutide as with for the Treatment of Obesity Semaglutide vs Tirzepatide for Weight

The FDA is currently reviewing the new drug application

It is currently undergoing phase 3 of clinical trials and it is predicted that it will be submitting its application for approval sometime in 2026 or 2027

Headaches occur in approximately 1015% of patients beginning GLP-1 receptor agonist therapy, making them one of the more common early side effects reported during the first two weeks of treatment

Combined with compounded semaglutide at $189/mo month-to-month, or from $149/mo on the 6-month plan, this genetic clarity enables safer, more effective treatment planning tailored to your biology

Some fiber supplements: Although fiber supplements are commonly prescribed to treat constipation, some forms of fiber such as wheat bran decrease the water content of stool, which may worsen constipation (29)

Ginger tea, peppermint, and lemon water are particularly helpful for many patients managing GLP-1 side effects